Larimar Therapeutics, Inc.
LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31
Reports and events: 238 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2920:01 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001193125-24-122191 |
| 2024-03-1520:37 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-24-000378 |
| 2024-03-1420:25 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031529 |
| 2024-03-1420:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-031467 |
| 2024-03-1120:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-029236 |
| 2024-02-1621:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-038473 |
| 2024-02-1619:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-24-000244 |
| 2024-02-1522:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-24-000234 |
| 2024-02-1411:06 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-24-014919 |
| 2024-02-1212:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-013563 |
| 2023-11-1418:51 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-063517 |
| 2023-11-1412:14 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-063347 |
| 2023-10-0320:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-249962 |
| 2023-08-1412:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-042070 |
| 2023-08-1020:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041293 |
| 2023-08-1011:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040946 |
| 2023-07-2511:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-034217 |
| 2023-07-1720:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-033196 |
| 2023-06-0120:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-025691 |
| 2023-05-1520:03 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-022187 |
| 2023-05-1511:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-021953 |
| 2023-05-1220:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-021747 |
| 2023-04-1120:05 ET | DEF 14A | Proxy statementPeriod 2023-05-09 | 0001193125-23-097798 |
| 2023-04-0620:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-093965 |
| 2023-03-1721:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-23-000345 |
| 2023-03-1420:03 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007855 |
| 2023-03-1411:32 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-069624 |
| 2023-02-0721:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-026958 |
| 2023-01-0921:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-000506 |
| 2022-11-1014:20 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024223 |
| 2022-11-1012:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-024139 |
| 2022-10-2012:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-019769 |
| 2022-09-1621:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-22-001271 |
| 2022-09-1413:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-244317 |
| 2022-09-1411:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-244248 |
| 2022-08-1120:32 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016917 |
| 2022-08-1120:13 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-016881 |
| 2022-05-1220:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-22-148643 |
| 2022-05-1218:23 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009590 |
| 2022-05-1211:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-148057 |
| 2022-04-1210:06 ET | DEF 14A | Proxy statementPeriod 2022-05-10 | 0001193125-22-102289 |
| 2022-04-1120:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-101650 |
| 2022-03-2516:37 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004637 |
| 2022-03-2511:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-084528 |
| 2022-02-2813:16 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-055857 |
| 2022-02-1422:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-042209 |
| 2021-11-1217:56 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004331 |
| 2021-11-1212:21 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-327323 |
| 2021-08-1214:29 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-244068 |
| 2021-08-1214:28 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043701 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.